Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Zinaida Good(Parker Institute for Cancer Immunotherapy), Jay Y. Spiegel(University of Miami), Bita Sahaf(Stanford University), Meena Malipatlolla(Stanford University), Zachary Ehlinger(Stanford University), Sreevidya Kurra(Western Michigan University), Moksha H. Desai(Stanford University), Warren D. Reynolds(Stanford University), Anita Wong Lin(University of California, Berkeley), Panayiotis Vandris(Stanford University), Fang Wu(Stanford University), Snehit Prabhu(Stanford University), Mark Hamilton(Stanford University), John Tamaresis(Stanford University), Paul Hanson(Stanford University), Shabnum Patel(Syneos Health (India)), Steven A. Feldman(Stanford University), Matthew J. Frank(Stanford University), John H. Baird(City Of Hope National Medical Center), Lori Muffly(Stanford University), Gursharan K. Claire(Stanford University), Juliana Craig(University of Wisconsin–Madison), Katherine A. Kong(Stanford University), Dhananjay Wagh(Stanford University), John A. Coller(Stanford University), Sean C. Bendall(Parker Institute for Cancer Immunotherapy), Robert Tibshirani(Stanford University), Sylvia K. Plevritis(Stanford University), David B. Miklos(Stanford Blood Center), Crystal L. Mackall(Parker Institute for Cancer Immunotherapy)
Cited by 240Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis